Regulation of G protein-coupled receptors by allosteric ligands

Jonathan Robert David Lane, Alaa Abdul Ridha, Meritxell Canals

Research output: Contribution to journalArticleResearchpeer-review

42 Citations (Scopus)


Topographically distinct, druggable, allosteric sites may be present on all G protein-coupled receptors (GPCRs). As such, targeting these sites with synthetic small molecules offers an attractive approach to develop receptor-subtype selective chemical leads for the development of novel therapies. A crucial part of drug development is to understand the acute and chronic effects of such allosteric modulators at their corresponding GPCR target. Key regulatory processes including cell-surface delivery, endocytosis, recycling, and down-regulation tightly control the number of receptors at the surface of the cell. As many GPCR therapeutics will be administered chronically, understanding how such ligands modulate these regulatory pathways forms an essential part of the characterization of novel GPCR ligands. This is true for both orthosteric and allosteric ligands. In this Review, we summarize our current understanding of GPCR regulatory processes with a particular focus on the effects and implications of allosteric targeting of GPCRs.
Original languageEnglish
Pages (from-to)527 - 534
Number of pages8
JournalACS Chemical Neuroscience
Issue number4
Publication statusPublished - 2013

Cite this